Artwork

Innehåll tillhandahållet av Mark Davison. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Mark Davison eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

Hazel Jones: Enhancing Drug Discovery with 3D Genomics

42:10
 
Dela
 

Manage episode 440125983 series 3556156
Innehåll tillhandahållet av Mark Davison. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Mark Davison eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

What role does 3D genomics have in drug discovery?
In this episode I am joined by Hazel Jones, CEO of Enhanc3d Genomics, to find out more about this cutting-edge technology.
Hazel is a dynamic and flexible senior leader with experience of oncology research, both in pharma/biotech and an academic/charity setting. Making her insights into the workings of not for profit and big pharma invaluable.
We discuss her work at Enhanc3d Genomics and the role of 3D genomics in uncovering the regulatory elements of the genome. As well as its potential in identifying new drug targets and biomarkers. Hazel also shares insights into the challenges and opportunities in the biotech industry and the importance of networking and collaboration to help projects succeed.
Hazel has a wealth of knowledge not just in her specialism but how the whole industry works, so sit tight and get ready to learn!
“We've made huge discoveries both in drugs and diagnosis through genomics.” – Hazel Jones

You’ll hear about:

01:13 - What do Enhanc3d Genomics do?

05:16 - Hazel's experience in not for profit

10:11 - Behind the scenes in big pharma

15:53 - How promoters and enhancers work

24:36 - Regulators and the potential for side effects

31:59 - Hazel on raising money

36:40 - Prevention rather than the cure

37:51 - Hazel on Conexen

Connect with Hazel:
LinkedIn - https://www.linkedin.com/in/joneshazel/
Enhanc3d Genomics - https://enhanc3d-genomics.com/

Connect with me:
LinkedIn: https://www.linkedin.com/in/markdavison100/
Grant Instruments: https://www.grantinstruments.com/
Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/

  continue reading

Kapitel

1. Hazel Jones: Enhancing Drug Discovery with 3D Genomics (00:00:00)

2. What do Enhanc3d Genomics do? (00:01:13)

3. Hazel's experience in not for profit (00:05:16)

4. Behind the scenes in big pharma (00:10:11)

5. How promoters and enhancers work (00:15:53)

6. Regulators and the potential for side effects (00:24:36)

7. Hazel on raising money (00:31:59)

8. Prevention rather than the cure (00:36:40)

9. Hazel on Conexen (00:37:51)

15 episoder

Artwork
iconDela
 
Manage episode 440125983 series 3556156
Innehåll tillhandahållet av Mark Davison. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Mark Davison eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

What role does 3D genomics have in drug discovery?
In this episode I am joined by Hazel Jones, CEO of Enhanc3d Genomics, to find out more about this cutting-edge technology.
Hazel is a dynamic and flexible senior leader with experience of oncology research, both in pharma/biotech and an academic/charity setting. Making her insights into the workings of not for profit and big pharma invaluable.
We discuss her work at Enhanc3d Genomics and the role of 3D genomics in uncovering the regulatory elements of the genome. As well as its potential in identifying new drug targets and biomarkers. Hazel also shares insights into the challenges and opportunities in the biotech industry and the importance of networking and collaboration to help projects succeed.
Hazel has a wealth of knowledge not just in her specialism but how the whole industry works, so sit tight and get ready to learn!
“We've made huge discoveries both in drugs and diagnosis through genomics.” – Hazel Jones

You’ll hear about:

01:13 - What do Enhanc3d Genomics do?

05:16 - Hazel's experience in not for profit

10:11 - Behind the scenes in big pharma

15:53 - How promoters and enhancers work

24:36 - Regulators and the potential for side effects

31:59 - Hazel on raising money

36:40 - Prevention rather than the cure

37:51 - Hazel on Conexen

Connect with Hazel:
LinkedIn - https://www.linkedin.com/in/joneshazel/
Enhanc3d Genomics - https://enhanc3d-genomics.com/

Connect with me:
LinkedIn: https://www.linkedin.com/in/markdavison100/
Grant Instruments: https://www.grantinstruments.com/
Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/

  continue reading

Kapitel

1. Hazel Jones: Enhancing Drug Discovery with 3D Genomics (00:00:00)

2. What do Enhanc3d Genomics do? (00:01:13)

3. Hazel's experience in not for profit (00:05:16)

4. Behind the scenes in big pharma (00:10:11)

5. How promoters and enhancers work (00:15:53)

6. Regulators and the potential for side effects (00:24:36)

7. Hazel on raising money (00:31:59)

8. Prevention rather than the cure (00:36:40)

9. Hazel on Conexen (00:37:51)

15 episoder

Alla avsnitt

×
 
Loading …

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

 

Snabbguide